Načítá se...
Chromatin structure predicts epigenetic therapy responsiveness in sarcoma
To formally explore the potential therapeutic effect of histone deacetylase inhibitors (HDACIs) and DNA-methyltransferase inhibitors (DNA-MIs) on sarcomas, we treated a large sarcoma cell line panel with five different HDACIs in the absence and presence of the DNA-MI decitabine. We observed that the...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3075587/ https://ncbi.nlm.nih.gov/pubmed/21216937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0724 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|